Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug approvals
Pharma
FDA clears Pfizer spinout SpringWorks' rare disease drug Ogsiveo
Besides this approval, SpringWorks sees potential for Ogsiveo to boost the efficacy of BCMA-targeted multiple myeloma therapies.
Angus Liu
Nov 27, 2023 6:18pm
FDA clears Bristol Myers cancer drug from Turning Point buy
Nov 16, 2023 11:10am
Coherus spurns 'heavily discounted' pricing for new PD-1 med
Oct 30, 2023 12:10pm
Delayed FDA nod moves Lilly into crowded ulcerative colitis field
Oct 27, 2023 11:10am
FDA approves GSK's Jakafi challenger in blood cancer
Sep 15, 2023 4:16pm
Otsuka, Astellas, Exelixis and Insilico—Fierce Pharma Asia
Sep 15, 2023 9:00am
